Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2024-11-29
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients
NCT05888584
Improving Access to Lung Cancer Clinical Trials
NCT05780164
Implementation of a Tool to Identify Social Weaknesses in the Cancer Care Pathway
NCT04015895
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
NCT06086574
Improving Lung Cancer Screening Adherence by Overcoming Barriers for Vulnerable Populations
NCT04969341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A confirmed diagnosis of cancer
* Patient planned to or is receiving treatment at The Clatterbridge Cancer Centre NHS Foundation Trust
* Able to provide informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Clatterbridge Cancer Centre NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clatterbridge Cancer Centre
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
321327
Identifier Type: OTHER
Identifier Source: secondary_id
C1337
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.